CD4 and COVID-19: It seems that the HLA restricted CD4+ as well as CD8+ T-cell epitopes are comprehensively distributed in the whole SARS-CoV-2 proteome (39), therefore, the induction of broadly protective cellular responses is a feasible strategy to enhance the effectiveness of COVID-19 vaccines.